WGS — GeneDx Holdings Corp.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1818331 ·
Last close
$47.29
Market Cap
$1.42B
52W High
$170.87
52W Low
$32.21
ADV30
1,016,818
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 123,101,000 | 86,060,000 | -9,528,000 | -12,327,000 | 526,484,000 | 96,139,000 | 281,795,000 |
| Jun 2026 | 114,440,000 | 78,238,000 | -15,243,000 | -17,740,000 | 481,486,000 | 60,317,000 | 237,265,000 |
| Mar 2026 | 102,254,000 | 68,211,000 | -26,184,000 | -63,316,000 | 506,301,000 | 93,924,000 | 252,177,000 |
| Dec 2025 | 120,989,000 | 84,268,000 | -14,235,000 | -17,666,000 | 523,710,000 | 104,997,000 | 215,528,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-75,078,000
Investing CF
$-41,375,000
Financing CF
$116,627,000
CapEx
$-26,138,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.44
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,466,878,000
Inventory
$21,703,000
Receivables
$92,131,000
ST Investments
$73,979,000
EBIT TTM
$-103,532,000
Pretax Income TTM
$-111,208,000
Interest Exp TTM
$4,243,000
Analysts
8
Yahoo Snapshot (yfinance, live)
Total Revenue
$460,784,000
EBITDA
$-36,656,000
Free Cash Flow
$-70,288,000
Enterprise Value
$1,614,925,440
Total Cash
$170,118,000
Total Debt
$215,384,000
Shares Out
29,972,493
Trailing EPS
$-3.76
Book Value
$8.17
ROE
-41.4%
ROA
-7.7%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 427,539,000 | -13,077,000 | -21,021,000 | 523,710,000 | 215,528,000 | 308,182,000 | 33,279,000 |
| Dec 2024 | 305,450,000 | -23,213,000 | -52,286,000 | 419,380,000 | 174,133,000 | 245,247,000 | -28,496,000 |
| Dec 2023 | 202,566,000 | -170,194,000 | -175,767,000 | 418,756,000 | 190,739,000 | 228,017,000 | -180,147,000 |
| Dec 2022 | 234,694,000 | -457,507,000 | -548,980,000 | 490,942,000 | 237,237,000 | 253,705,000 | -319,155,000 |
TTM Snapshot
Revenues TTM
$454,426,000
NetIncome TTM
$-106,357,000
OpCashFlow TTM
—
Assets (Latest)
$481,486,000
Forward EPS
$1.26
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LMRI | Lumexa Imaging Holdings, Inc. | $1.41B | $14.63 | — |
| USPH | U S PHYSICAL THERAPY INC /NV | $1.45B | $97.34 | — |
| TDOC | Teladoc Health, Inc. | $1.55B | $8.49 | — |
| INNV | InnovAge Holding Corp. | $1.29B | $9.42 | — |
| PNTG | Pennant Group, Inc. | $1.28B | $36.50 | — |
News headlines (Yahoo Finance, 1h cache)
GeneDx Holdings (WGS) Says Sequencing Guided Care In More Than 60% Of Patients
2026-11-13 10:15 · Yahoo
Who Is Paying For GeneDx's Cash Burn?
2026-11-12 17:44 · Yahoo
GeneDx to Participate in Upcoming Investor Conferences
2026-11-11 21:05 · Yahoo
GeneDx (WGS) Stock Looks About Right After Fresh Sales Progress
2026-11-11 11:12 · Yahoo
Is GeneDx Holdings (WGS) Undervalued After Third Quarter 2026 Results?
2026-11-11 09:11 · Yahoo
Why GeneDx Holdings Stock Just Dropped 16.6%
2026-11-10 22:06 · Yahoo
GeneDx Holdings Corp. Q3 2026 Earnings Call Summary
2026-11-10 13:30 · Yahoo
GeneDx (WGS) Q3 2026 Earnings Call Transcript
2026-11-10 07:02 · Yahoo
GeneDx Holdings Corp (WGS) (Q3 2026) Earnings Call Highlights: Revenue Hits $123. ...
2026-11-10 05:10 · Yahoo
GeneDx Q3 Earnings Call Highlights
2026-11-10 02:14 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.